(Press-News.org) Contact information: Jen Gundersen
jeg2034@med.cornell.edu
646-317-7402
Weill Cornell Medical College
Half of psychiatrists reject private and federal insurance, preferring cash
Researchers warn that just when the need for mental health services is recognized on a national level, access to help is declining at an alarming rate
NEW YORK (December 11, 2013) -- Access to mental health care has become a prominent issue in Congress following mass shootings around the country. But a new study in JAMA Psychiatry, led by researchers at Weill Cornell Medical College, suggests that unless those in need of help have deep pockets, they might have a hard time finding a psychiatrist that will provide the needed services.
The study found that psychiatrists increasingly refuse to accept Medicare and Medicaid, or even private insurance, as payment. In the five years between 2005 and 2010, investigators found that the percentage of psychiatrists who accepted private insurance dropped by 17 percent, to 55 percent, and those that took Medicare declined by almost 20 percent, also to about 55 percent. Their acceptance of Medicaid is 43 percent, the lowest among all medical specialties.
"More than physicians in other specialties, psychiatrists accept lower rates of insurance, and those who don't take insurance are likely charging cash for their services," says the study's lead author, Dr. Tara F. Bishop, an assistant professor in the Department of Public Health and Medicine at Weill Cornell Medical College.
The number of psychiatrists is also quickly dwindling -- a drop of 14 percent from 2000 to 2008 -- because psychiatrists are retiring and medical students are not choosing to go into psychiatry. These issues may lead to a perfect storm of untreated mental health issues nationwide, Dr. Bishop says.
"In the current climate, where the need for increased mental health services is now recognized, I suspect our study conclusions will be an eye opener for both the public and the medical community," she says. "I must say we were surprised by the findings. No prior studies have documented such striking differences in insurance acceptance rates by psychiatrists and physicians of other specialties -- primarily because no one has looked closely at the issue."
These low insurance rates may "impact recent calls for increased access to mental health services, and if the trend of declining acceptance rates continues then the impact may be even more significant," the researchers say in their study.
"For example, not only are there fewer physicians who can help people with moderate to severe symptoms of mental illness, those patients must then try to find a doctor who will take their insurance," Dr. Bishop says. "This is not a formula for success."
Additionally, with the growth of the population, need for services will increase, she says. The Centers for Disease Control and Prevention estimates that a quarter of adults in the United States report having a mental illness at any given time, and that about half of adults will suffer from one in their lifetime.
While the term "mental illness" is broad, and includes depression and anxiety that general care doctors can help with, those doctors are overwhelmed, says Dr. Bishop, who is herself a primary care physician. "We don't have a work force that can keep up with all the issues -- mental health aside -- in our growing and aging population."
Solo practitioners less likely to accept insurance
The Weill Cornell investigators, working with researchers from Columbia University and the University of California, San Francisco, used a nationally representative survey to conduct their study. That database is the National Ambulatory Medical Care Survey (NAMCS), administered by the Centers for Disease Control's National Center for Health Statistics (NCHS). It represents about 90 percent of the ambulatory care delivered in the United States -- the care provided in private physician offices or group practices, Dr. Bishop says.
The database does not include psychiatric outpatient clinics linked to hospitals or large medical centers. "Some patients with some of the most severe mental illnesses, such as schizophrenia or bipolar disease, may be cared for in those clinics, and this database does not capture that population," she says.
The average number of physicians surveyed each year by the NAMCS is about 1,250, and psychiatrists represent 5.5 percent of these doctors.
The researchers don't know why psychiatrists are increasingly rejecting insurance payment; questions about motivation were not included in the survey. "But we can speculate that insurance provides lower reimbursement rates than psychiatrists feel cover the costs of care," Dr. Bishop says.
Part of the reason for this reluctance may be that it takes considerable time -- typically, an hour or so -- to provide counseling and therapy, and therefore, psychiatrists may not be able to see as many patients in a day as physicians of other specialties can, Dr. Bishop says.
Additionally, more psychiatrists than physicians of other specialties practice alone -- 60 percent -- and accepting insurance entails considerable administrative work, she says. The study found that these solo practitioners are less likely to accept all types of insurance.
These issues could be resolved if incentives are offered to medical students to pursue psychiatry, and if insurance payments to practicing psychiatrists are increased, the researchers say.
Dr. Bishop is delving deeper into the issues her study raises. She plans to interview psychiatrists to understand why they are not accepting insurance, and what can be done to change their minds.
###
Co-authors of the study are Dr. Matthew Press, from Weill Cornell Medical College, Dr. Salomeh Keyhani, from the University of California, San Francisco, and Dr. Harold Alan Pincus, from Columbia University and NewYork-Presbyterian Hospital. Dr. Bishop is supported by a National Institute on Aging Career Development Award (K23AG043499). She and Dr. Press are Nanette Laitman Clinical Scholars in Public Health at Weill Cornell Medical College. Dr. Keyhani is supported by a VA HSR&D Career Development Award.
Weill Cornell Medical College
Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances -- including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.
Office of External Affairs
Weill Cornell Medical College
tel: 646.317.7401
email: pr@med.cornell.edu
Follow WCMC on Twitter and Facebook
Half of psychiatrists reject private and federal insurance, preferring cash
Researchers warn that just when the need for mental health services is recognized on a national level, access to help is declining at an alarming rate
2013-12-12
ELSE PRESS RELEASES FROM THIS DATE:
Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments
2013-12-12
Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments
Research by University of Ottawa and University of Calgary scientists opens the door to more effective treatments for life-threatening disease
The ...
Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center
2013-12-12
Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center
Molecular subtyping enables more accurate prognosis and treatment selection, according to research presented at San Antonio conference
...
Neuroscience method of optogenetics as good as electrical stimulation
2013-12-12
Neuroscience method of optogenetics as good as electrical stimulation
PROVIDENCE, R.I. [Brown University] — Neuroscientists are eagerly, but not always successfully, looking for proof that optogenetics – a celebrated technique that uses pulses of visible light ...
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant
2013-12-12
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant
SAN ANTONIO — Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery ...
Exercise improves drug-associated joint pain in breast cancer survivors
2013-12-12
Exercise improves drug-associated joint pain in breast cancer survivors
SAN ANTONIO — Breast cancer survivors taking aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane experienced a reduction in joint pain if they exercised ...
New drug combination delayed disease progression for subgroup of women with metastatic breast cancer
2013-12-12
New drug combination delayed disease progression for subgroup of women with metastatic breast cancer
SAN ANTONIO — Adding the drug dasatinib to a standard antihormone therapy, letrozole, doubled the time before disease progressed for women with ...
Antihormone therapy anastrozole may provide new option for breast cancer prevention
2013-12-12
Antihormone therapy anastrozole may provide new option for breast cancer prevention
SAN ANTONIO — Breast cancer incidence among postmenopausal women at high risk for developing the disease was significantly reduced by the antihormone therapy ...
Combining mutants results in 5-fold lifespan extension in C. elegans
2013-12-12
Combining mutants results in 5-fold lifespan extension in C. elegans
Research highlights possibility of combination therapy for aging
What are the limits to longevity? New research in simple animals suggests that combining mutants can lead to radical ...
Temple scientists studying mitochondrial calcium handling yield new disease targets
2013-12-12
Temple scientists studying mitochondrial calcium handling yield new disease targets
(Philadelphia, PA) – When things go wrong, cells turn to built-in safety mechanisms for survival. One of those mechanisms involves calcium uptake by mitochondria, ...
Partially blocking blood vessels' energy source may stop cancer growth, blindness & other conditions
2013-12-12
Partially blocking blood vessels' energy source may stop cancer growth, blindness & other conditions
VIDEO:
This is a confocal time-lapse video imaging of a control (A; DMSO) ...
LAST 30 PRESS RELEASES:
Lightweight multi-wavelength network model for efficient and high-fidelity full-color 3D holographic display
Halide perovskite volatile unipolar Nanomemristor
New foundation model reveals how cells are organized in tissues
Printing with fields: Reprogramming matter at the smallest scales
Reimagine biocatalysis: Turning DNA phosphates into chiral catalysts
Potential of new materials for absorbing 99.5% of light on solar towers demonstrated at the EHU
Dr. Xin Jin named 2026 Peter Gruss Young Investigator
New antibody therapy reawakens immune system to fight pancreatic cancer
David B. Allison, PhD (Baylor College of Medicine), Lauren Hunt PhD, RN, FNP (UCSF), and Arlan Richardson, PhD (University of Oklahoma Health Sciences) to be honored with AFAR annual scientific Awards
145 families receive a diagnosis with new genomic method
Postpartum psychosis: International experts seek to save lives of mothers, babies
Scientists build detailed map of the developing human brain, opening new pathways for Parkinson’s treatment
USF study finds smarter way to train employees to thwart phishing scams
Antimicrobial peptides can reduce salmonella in chickens
Short fasts do not impair thinking ability in healthy adults
Bill Gropp named chair of CRA’s Computing Community Consortium
Novel S-Scheme photocatalyst efficiently purifies antibiotic-contaminated water
Plugging nanoscopic cracks to make hydrogen cleaner and cheaper
Study: More states eliminating insurance hurdles for opioid use disorder medications
Women missing cardiac rehabilitation, despite key benefits
Exposure to more artificial light at night may raise heart disease risk
Optimal cardiovascular health among people with Type 2 diabetes may offset dementia risk
Quick CPR from lay rescuers can nearly double survival for children after cardiac arrest
An AI tool detected structural heart disease in adults using a smartwatch
Assessing heart-pumping glitch may reduce stroke risk in adults with heart muscle disease
Low-dose aspirin linked to lower cardiovascular event risk for adults with Type 2 diabetes
Long-term use of melatonin supplements to support sleep may have negative health effects
Healthy lifestyle combined with newer diabetes medications lowered cardiovascular risk
Researchers pinpoint target for treating virus that causes the stomach bug
Scientists produce powerhouse pigment behind octopus camouflage
[Press-News.org] Half of psychiatrists reject private and federal insurance, preferring cashResearchers warn that just when the need for mental health services is recognized on a national level, access to help is declining at an alarming rate